Table 4. miTranscriptome-defined LUAD lineage-specific lncRNAs.

miTranscriptome	Alternate IDs	Position (GRCh37/hg19)	Genomic Context	Patient Outcome
CAT1100.3	PVT1	chr8:128996355-129130070 (−)	Adjacent to MYC oncogene	Correlated to MYC expression and tumor progression. PVT1 presence indicates poorer prognosis for patients
DPYD-AS1.2	NR_046590.1	chr1:97720954-97751573 (+)	Antisense to DYPD	DYPD implicated in increased toxicity to patients treated with 5FU.
LACAT24	LOC101927132	chr16:47936832-47961855 (+)	Intergenic	Unknown
LACAT8.1	LACAT8	chr12:131471968-131478539 (−)	Antisense to GPR133 (ADGRD1)	GPR133 upregulation correlated to poorer survival in GBM

miTranscriptome-calcuated lncRNAs with lineage specificity to LUAD.